Who is sponsoring NCT03610386?

NCT03610386 is sponsored by University Hospital, Brest.

What drugs are being tested in NCT03610386?

Interventions in NCT03610386: Adding menthoxypropanediol to the biopsy, No adding menthoxypropanediol to the biopsy.

What condition does NCT03610386 study?

NCT03610386 studies Atopic Dermatitis.

Is NCT03610386 still recruiting?

NCT03610386 is currently completed. Last updated 28 December 2021.

Last reviewed 2021-12-28 · How we verify

NCT03610386: DA-TRPM8

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of an Anti-TRPM8 in the Atopic Dermatitis Pruritus

Completed NA Last updated 28 December 2021

What this trial tests

NA trial testing Adding menthoxypropanediol to the biopsy in Atopic Dermatitis in 10 participants. Completed in 29 January 2019.

Timeline

21 November 2018

Primary endpoint
29 January 2019

29 January 2019

Quick facts

Lead sponsor	University Hospital, Brest
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	21 November 2018
Primary completion	29 January 2019
Estimated completion	29 January 2019
Sites	1 location across France

Drugs / interventions tested

Adding menthoxypropanediol to the biopsy
No adding menthoxypropanediol to the biopsy

Conditions studied

Atopic Dermatitis — all drugs for Atopic Dermatitis →

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with Atopic Dermatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to analyse the effect of the menthoxypropanediol, a derivative of menthol, on the pruritus of atopic dermatitis (ex vivo study).

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases.
Zhang M, Ma Y, Ye X, Zhang N, et al · · 2023 · cited 303× · PMID 37402746 · DOI 10.1038/s41392-023-01464-x
TRPM8 Channels: Advances in Structural Studies and Pharmacological Modulation.
Izquierdo C, Martín-Martínez M, Gómez-Monterrey I, González-Muñiz R. · · 2021 · cited 54× · PMID 34445208 · DOI 10.3390/ijms22168502
New and Upcoming Topical Treatments for Atopic Dermatitis: A Review of the Literature.
Sideris N, Paschou E, Bakirtzi K, Kiritsi D, et al · · 2022 · cited 28× · PMID 36078904 · DOI 10.3390/jcm11174974
Physiological functions and pharmacological targeting of transient receptor potential channels.
Chubanov V, Grimm C, Hill K, Schaefer M, et al · · 2025 · PMID 41118703 · DOI 10.1016/j.pharmr.2025.100089

Verify or expand the search:

Other recruiting trials for Atopic Dermatitis

Currently open trials in the same condition.

NCT07262983 — Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopi · Phase 1 · recruiting
NCT07445919 — A Clinical Study to Evaluate SM17 for Atopic Dermatitis · Phase 2 · recruiting
NCT07488065 — A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants · Phase 1 · recruiting
NCT07467564 — The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatit · recruiting
NCT07358156 — A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and E · Phase 1 · recruiting

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03610386 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 28 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03610386.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing